Biotechnology (11) | Trust Agreements (11)

Browse by Company

Recent Contracts

STING Agonist Contingent Value Rights Agreement, dated as of November 20, 2020, by and between Spring Bank Pharmaceuticals, Inc., F-star Therapeutics Limited, Computershare Inc.,... (Spring Bank Pharmaceuticals, Inc., Filed With SEC on November 20, 2020)
STING Antagonist Contingent Value Rights Agreement, dated as of November 20, 2020, by and between Spring Bank Pharmaceuticals, Inc., F-star Therapeutics Limited, Computershare... (Spring Bank Pharmaceuticals, Inc., Filed With SEC on November 20, 2020)
Contingent Value Rights Agreement, dated October 2, 2020, by and between Aduro Biotech, Inc. and Computershare Trust Company, N.A (ADURO BIOTECH, INC., Filed With SEC on November 5, 2020)
Section 382Rights Agreement Datedas of August 14, 2020 byand between ENZON PHARMACEUTICALS, INC. and CONTINENTALSTOCK TRANSFER & TRUST COMPANY as Rights Agent (ENZON PHARMACEUTICALS, INC., Filed With SEC on August 14, 2020)
Contingent Value Rights Agreement, dated as of August 6, 2020, by and among Unum Therapeutics Inc., Computershare Inc. and Computershare Trust Company, N.A (Unum Therapeutics Inc., Filed With SEC on August 10, 2020)
Collateral Access Agreement by and between AquaBounty Technologies, Inc. and First Farmers Bank and Trust, dated as of July 31, 2020 (AquaBounty Technologies, Inc., Filed With SEC on August 6, 2020)
Environmental Indemnity Agreement by and among AquaBounty Technologies, Inc., AquaBounty Farms Indiana LLC, and First Farmers Bank and Trust, dated as of July 31, 2020 (AquaBounty Technologies, Inc., Filed With SEC on August 6, 2020)
Contingent Value Rights Agreement, dated as of December 30, 2019, by and among the Company, Grand Rapids Holders Representative, LLC, Computershare Inc. and Computershare Trust... (Gemphire Therapeutics Inc., Filed With SEC on December 31, 2019)
Section 382 Rights Agreement, dated as of December 3, 2019, between Merrimack Pharmaceuticals, Inc. and Computershare Trust Company, N.A., as Rights Agent (MERRIMACK PHARMACEUTICALS INC, Filed With SEC on December 3, 2019)
Form of Amended Trust Agreement (Bison Capital Acquisition Corp., Filed With SEC on March 5, 2019)